Table 4 Cannabis ever-users report earlier-onset and more distressing psychotic experiences than never-users.

From: Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank

 

Prevalence of self-reported psychotic experiences with particular qualities (ever- vs. never-users)

 

Early-onset (<18 years old)

Distressing

Associated with help-seeking

Had a psychotic experience that was ________

1.9% vs. 0.8%

AOR = 1.90

[1.64, 2.20]

3.0% vs. 1.5%

AOR = 1.62

[1.45, 1.81]

1.6% vs. 0.8%

AOR = 1.45

[1.25, 1.70]

Had a psychotic experience that was not ________

4.1% vs. 2.5%

AOR = 1.52

[1.38, 1.66]

4.1% vs. 2.6%

AOR = 1.50

[1.37, 1.64]

5.6% vs. 3.3%

AOR = 1.55

[1.43, 1.68]

Difference

FDR = 0.5%

(p = 1 × 10−5)

FDR = 9%

(p = 0.1)

FDR = 81%

(p = 0.3)

  1. FDRs are derived from Benjamini–Hochberg correction for three tests; square brackets denote 95% confidence intervals.
  2. FDR false discovery rate.
  3. The bold values are purely for visual emphasis.